Precisely defining the roles of specific cell types is an intriguing frontier in the study of intact biological systems and has stimulated the rapid development of genetically encoded tools for observation and control. however, targeting these tools with adequate specificity remains challenging: most cell types are best defined by the intersection of two or more features such as active promoter elements, location and connectivity. here we have combined engineered introns with specific recombinases to achieve expression of genetically encoded tools that is conditional upon multiple cell-type features, using Boolean logical operations all governed by a single versatile vector. We used this approach to target intersectionally specified populations of inhibitory interneurons in mammalian hippocampus and neurons of the ventral tegmental area defined by both genetic and wiring properties. this flexible and modular approach may expand the application of genetically encoded interventional and observational tools for intact-systems biology.
Precisely defining the roles of specific cell types is an intriguing frontier in the study of intact biological systems and has stimulated the rapid development of genetically encoded tools for observation and control. however, targeting these tools with adequate specificity remains challenging: most cell types are best defined by the intersection of two or more features such as active promoter elements, location and connectivity. here we have combined engineered introns with specific recombinases to achieve expression of genetically encoded tools that is conditional upon multiple cell-type features, using Boolean logical operations all governed by a single versatile vector. We used this approach to target intersectionally specified populations of inhibitory interneurons in mammalian hippocampus and neurons of the ventral tegmental area defined by both genetic and wiring properties. this flexible and modular approach may expand the application of genetically encoded interventional and observational tools for intact-systems biology.
Understanding how defined cell types contribute to organism function is a central goal in biology and an acute challenge in neuroscience 1 . Recent development of optically modulated, genetically encoded tools for testing necessity and sufficiency of precise activity patterns 2, 3 has enabled the causal linkage of neuronal activity to circuit dynamics and behavior, but these tools are only as good as their targetability within intact systems. Cell types 4 defined by gene expression pattern are targetable via either transgenic or viral approaches. Although genetically specific, the transgenic approach (inserting genes into defined loci to recapitulate native expression patterns) requires a new animal strain to be generated for each tool. In contrast, viruses are rapidly adaptable, with flexibility in tool payload and injection location. However, suitable promoter fragments (to drive expression of genetically targeting cells with single vectors using multiple-feature Boolean logic encoded tools) must be short, strong and specific; the viral capsid determines packaging efficiency and limits this strategy 3 . Recent approaches have combined the versatility of viral intervention with fuller genetic specificity conferred by the native chromosomal environment by pairing recombinase-dependent viruses with recombinase-expressing animal lines [5] [6] [7] [8] [9] [10] .
Although these approaches are elegant, they define cell types by only a single feature. Moreover, cells identical by one marker may serve different or even oppositional roles in physiology or behavior. Therefore, there is strong motivation to enable cell-type definition by multiple features, including multiple genetic and wiring features. A versatile viral system for defining cell types on the basis of multiple features 4 with only a single nontoxic virus (such as adeno-associated virus (AAV) or lentivirus) would powerfully enhance opportunities arising from development of control and observational tools. Cell targeting based on multiple genetic factors generally requires crossing transgenic animals expressing multiple recombinases with animals that express a gene only after recombinase-dependent excision of multiple STOP cassettes 11 . This method has yielded insights into development but is less scalable and flexible than a viral approach, and it is further complicated by transient developmental promoter activity (triggering expression of recombinases), potentially leading to tool expression in off-target adult cell populations. Viral delivery in the adult would solve this temporal dilemma but is limited by viral payload limits 3 and the large size of STOP cassettes. Elegant approaches to logical gene expression using serine integrases have been described in vitro 12 but do not use recombinases typically built into transgenic mammals, and promoter manipulation strategies used in this approach can be 'leaky' in vivo, as we show here. Another approach splits proteins into two pieces, which are separately expressed; functionality results in only the cells that express both pieces. Though some function development of a cre-And Flp-dependent construct With the goal of targeting based on multiple features, we first paired Cre and Flp (chosen for the lack of detectable cross-reactivity and for increasingly available driver lines) to independently control relative directionality of the promoter and open reading frame (ORF; Supplementary Fig. 2 and ref. 12 ), but we observed inappropriate expression in vivo. The second strategy used nested recombinases to manipulate separate domains of the ORF (Supplementary Fig. 3 ), but this suffered from low expression.
Next we considered that introns, present in DNA but excised during mRNA processing at conserved exon-intron boundary sequences 18, 19 , could allow for insertion of recombinase machinery directly into the gene without affecting the protein product. We first tested whether introns introduced into ChR2-EYFP would degrade protein functionality and whether insertion of recombinase recognition sites into introns would impair splicing. We identified intron insertion sites that naturally mimic exonic splice sequences 18, 19 (Fig. 2a) .
HEK293 cells transfected with any of these constructs expressed EYFP, a result suggesting proper splicing. cDNAs synthesized by reverse transcription PCR (RT-PCR) from expressing cells and the source DNA were amplified by PCR using primer sets that spanned single introns (Fig. 2b) or both introns (Supplementary Fig. 4a ). We noted variability in the size of the amplicon from the DNA template, whereas cDNA bands were uniform, further suggesting proper splicing. After sequencing, introns were absent from all cDNAs synthesized with primers spanning a single intron (Fig. 2c) or spanning both introns (except intron 1 + lox, suggesting altered splicing in this modified intron; Supplementary Fig. 4b ). To assay ChR2 function, we transfected neuronal cultures (Fig. 2d) and obtained patch-clamp recordings (Fig. 2e) . Photocurrents were comparable to those of native ChR2-EYFP except for those of intron 2 + lox, which were larger (ChR2-EYFP: 1,422 ± 92 pA, n = 19 neurons; intron 2 + lox: 2,279 ± 247 pA, n = 5 neurons, P < 0.01; mean ± s.e.m. given throughout). Neither exon fragment of ChR2 was able to generate photocurrents in isolation (Supplementary Fig. 5 ). Finally, to assay these constructs in vivo, we injected lentivirus into mouse medial prefrontal cortex (mPFC). All constructs were expressed by 1 week, and expression was sustained through at least 4 weeks ( Fig. 2f and Supplementary Fig. 6 ). Together these results indicate that short introns inserted into the ChR2-EYFP coding sequence were properly spliced, did not impair gene function and enabled addition of heterologous sequence to the reading frame.
We next sought to optimize intron 1 given the impaired performance relative to that of intron 2. We identified differences between intron 1 and the consensus splice sequence 18, 19 ( Supplementary Fig. 4) , systematically changed these to match the consensus and then analyzed splicing by RT-PCR. The modified intron acceptor and intron 1 + lox template gave mixed products: one of these was the expected sequence, and the other was identical to the ChR2 sequence 139 bp 5′ to the expected splice site, likely revealing a cryptic splice site. Modification of either the exon or intron donor sequences produced a single, expected product, yet only the optimized intron donor sequence improved functional expression (ChR2-EYFP: 1,316 ± 120 pA, n = 8 neurons, intron donor: 2,219 ± 258 pA, n = 6 neurons, npg P < 0.05; Fig. 2g and Supplementary Fig. 4g ). We included this modification in all constructs using intron 1. We next combined recombinases (Cre and Flp) and engineered introns, using the DIO strategy to independently manipulate ORF fragments. To target cells expressing Flp AND Cre (Fig. 3a) , we inserted cDIO recombinase recognition cassettes in both introns and fDIO cassettes before and after the ChR2-EYFP coding sequence. Flp controlled the direction of the entire ORF, and the second exon was additionally controlled by Cre (Fig. 3b,c) Supplementary Fig. 7) , eliminating loxP and FRT to prevent trans recombination 23 with legacy recognition sites in some transgenic animals. We configured the first and third exons in the antisense direction, reversing their order, and left the second in the sense direction (C on /F on -ChR2-EYFP; Fig. 3b and Supplementary Fig. 8a ). Here, both recombinases are necessary to place all three exons into the sense configuration (Fig. 3c) , and either recombinase alone cannot produce a complete reading frame for ChR2 or EYFP.
To assess splicing, we prepared cDNA from HEK293 cells cotransfected to express Cre, Flp and the C on /F on -ChR2-EYFP construct. A shift in band size between transfected DNA and cDNA was readily apparent (Fig. 3d) ; splicing was confirmed by sequencing (Fig. 3e) . To assess functionality and specificity, we cotransfected cultured neurons or HEK293 cells with combinations of recombinases and C on /F on -ChR2-EYFP. EYFP expression was observed in only the neurons coexpressing Cre and Flp ( Fig. 3f and Supplementary Fig. 8a) , which is consistent with population flow cytometry data in HEK293 cells (100% of controls were fit by a single curve, and 100% of Cre-Flp cotransfections were fit by multiple curves; Fig. 3g ). Neurons expressing Cre, Flp and either ChR2-EYFP or C on /F on -ChR2-EYFP had comparable photocurrents (Fig. 3h) and light-evoked action potentials (Fig. 3i) . To examine functional specificity, we performed patchclamp experiments while blinded to ChR2 expression, basing our selection of neurons to be patched solely on recombinase expression. We found photocurrents in only the triple-transfected condition (Supplementary Fig. 9 ). Last, we assessed the impact of expressing inactive configurations of C on /F on -ChR2-EYFP and observed no deleterious effects on membrane properties or cell survival (Supplementary Fig. 10 ). These data indicate that integrating multiple recombinases with heterologous introns is a viable strategy for intersectional expression dependent on Cre and Flp recombinases, with expression levels comparable to those of intron-free, non-recombinase-dependent counterparts.
Function of cre and Flp-dependent chr2-eYFP in vivo
We next tested our intersectional expression strategy in vivo. We bred double-transgenic PV-p2A-Cre;SOM-IRES-Flp micewhere PV is parvalbumin, IRES is an internal ribosome entry site and SOM is somatostatin-and injected wild-type, Cre, Flp or Cre;Flp mice with AAV-DJ-C on /F on -ChR2-EYFP driven by the human synapsin (hSyn) or EF1α/HTLV (nEF) promoters in dorsal CA1 of hippocampus and in mPFC. Rodent CA1 contains PV + SOM − , PV − SOM + and PV + SOM + neurons 24 , whereas mPFC has PV + SOM − and PV -SOM + neurons but lacks double-positive (Fig. 4a) . No expression was observed in mPFC in any animal line (not shown).
We next analyzed ChR2 functionality in hippocampal slices prepared from PV-p2a-Cre;SOM-IRES-Flp animals injected with AAV-DJ-C on /F on -ChR2-EYFP driven by either hSyn or nEF. Using whole-cell patch clamp with biocytin-filled pipettes (Fig. 4b) , we found robust photocurrents that reliably drove action potentials ( Fig. 4c,d ). To characterize the identity of recorded cells, we stained for PV, SOM and biocytin (Fig. 4e,f) . Surprisingly, whereas all cells expressed SOM, only 8 of 27 were positive for PV, and even these were weakly stained. As some PV + SOM + cells are known to express only minimal PV 26,27 , we additionally processed slices for morphological characterization 28 . Of cells that were recovered with identifiable processes within the slice (17 of 33), 14 were classified as O-LM (oriens lacunosum moleculare), and the remaining 3 as bistratified (Fig. 4e,f) ; these cell types are known to express both PV and SOM 28 .
To further characterize cells expressing C on /F on -ChR2-EYFP, we stained and imaged thin slices and obtained data consistent with slice patching results: most C on /F on -ChR2-EYFP-expressing cells examined were immunohistochemically PV low SOM + or PV − SOM + but were present only in PV + SOM + animals (not in the single-marker transgenic lines; Fig. 4g-j) . Recombinase transgene expression need not be restricted to cells readily identifiable by immunostaining 29 ; we therefore crossed a separate PV-IRES-Cre mouse 30 C on /F on -CY EYFP [C] ChR2 [N] ChR2 [C] -EYFP [N] ChR2 [C] -EYFP [N] ChR2-EYFP EYFP [C] ChR2 [N] c npg expression of C on /F on -ChR2-EYFP in these double-transgenic mice is therefore likely driven by differences between the PV-p2a-Cre and PV-IRES-Cre transgenic lines themselves.
intrsect-based exclusion targeting: And not
This modular intron-and-recombinase targeting strategy potentially facilitates additional expression logic through reorientation of exons within the standard backbone. We next sought to target cells expressing 'recombinase X AND NOT recombinase Y' (C on /F off and C off /F on ; Fig. 5a ) by manipulating exon starting direction (Fig. 5a,b and Supplementary Fig. 8b,c) . We analyzed splicing in HEK293 cells and observed a large shift in cDNA amplicon size relative to transfected DNA (Fig. 5c ) and confirmed successful splicing by sequencing (Fig. 5d) . Neurons cotransfected with AND NOT constructs expressed ChR2-EYFP in the presence of the single activating recombinase but not in the presence of both Cre and Flp (Fig. 5e,f and Supplementary Fig. 8b,c) , which was consistent with flow cytometry population data (multiple populations were fit in 85-96% of matched single-recombinase transfections, and a single population was fit in 94-99% of doublerecombinase transfections; Fig. 5g ). These constructs exhibited comparable peak photocurrents (Fig. 5h ) and action potentials (Fig. 5i) . We noted that C on /F off -ChR2-EYFP had a depressed photocurrent relative to that of non-recombinase-dependent ChR2-EYFP; unlike C on /F on or C off /F on , C on /F off contains a recombinase cassette upstream of the ORF when active, with two ATG sequences in the spacer; scrambling these sequences improved the photocurrent (Supplementary Fig. 11 ).
Other applications, such as expression of fluorescent proteins alone, require adaptation of these multiple-recombinase tools to a single ORF. We achieved this by modifying the intron approach for use with EYFP (Supplementary Fig. 12) . Here, the 5′ and 3′ halves of EYFP are under control of separate recombinases, with a single intron containing Cre and Flp DIO cassettes. RT-PCR analysis using direction-specific primers suggested that EYFP sequence in C on /F on , C on /F off and C off /F on variants was amplified from recombinase-cotransfected HEK293 cells, but not source DNA, and was verified by sequencing. Flow cytometry npg indicated that EYFP was expressed only after cotransfection with appropriate recombinases, including AND NOT configurations, 5 days after transfection.
Projection targeting using multiple recombinases
We next combined fDIO and cDIO with projection-targeting strategies in order to restrict expression to cells defined by both genetic identity and projection pattern. Targeting dopaminergic (DA) cells of the ventral tegmental area (VTA) projecting to the nucleus accumbens (NAc) requires an intersectional strategy as neither all VTA-DA neurons (which project to numerous downstream areas) nor the entire VTA-NAc projection (which includes DA and non-DA cells 31 ) describes this population. We confirmed that projection-based targeting alone was insufficient by injecting the retrograde virus LT-HSV-mCherry-IRES-Cre ( Fig. 6a and Supplementary Fig. 13 ) into NAc and AAV-cDIO-ChR2-EYFP into VTA of wild-type mice (Fig. 6b) : only 48% of VTA EYFP + cells were positive for tyrosine hydroxylase (TH; the rate-limiting enzyme in dopamine production; Fig. 6c,d ). To target DA VTA-NAc neurons, we injected LT-HSV-lox-STOP-lox-mCherry-IRES-Flp into NAc of TH-Cre transgenic mice and AAV5-fDIO-ChR2-EYFP into VTA (Fig. 6e) . Only VTA neurons that both express Cre (TH + ) and are transduced by LT-HSV (NAc projecting) should express Flp and therefore activate fDIO-ChR2-EYFP. Indeed, 94% of VTA EYFP + cells were clearly mCherry + , and 93% of VTA EYFP + cells were TH + ; 60% of mCherry + TH + cells were EYFP + (Fig. 6f,g ). EYFP + fibers were abundant in NAc (Fig. 6f) but absent in the mPFC and basolateral amygdala, as expected 32 . Occasional sparse EYFP + fibers but no cell bodies were seen in negative controls lacking either Cre or Flp (Supplementary Fig. 14) . C on /F off EYFP [C] ChR2 [N] ChR2 Fig. 15 ). As criteria differentiating cell types become more sophisticated, three-term Boolean logic may become desirable (for example, a AND b AND c), heightening the value of identifying new recombinases, such as Cre relatives VCre and SCre 33 . In preliminary work, we synthesized human codonoptimized VCre and SCre, created vcDIO-and scDIO-ChR2-EYFP vectors, and transfected these alongside Cre, Flp and Dre in HEK293 cells (Fig. 6h) . Although scDIO/SCre did not function well, VCre induced EYFP expression in vcDIO-ChR2-EYFP (100% of samples fit to multiple curves) without cross-activity (93-98% of off-target DIOs were fit with a single curve; Fig. 6h 16 we observed Cre/rox cross-reaction in vitro and in vivo. Cre and Dre are both phage derived, with recognition sites sharing high homology in the 13-bp palindromic region that determines recombinase pairing. Sites used here could contribute to this cross-reaction, and other noncanonical sites may allow for their combined use. In any case, our results with Flp buttress its independence from Cre and establish it for the first time with Dre.
The multiple-recombinase and viral methods used in INTRSECT may synergize with strategies for tracing connectivity across networks, such as engineered viruses 34 . It will be important to validate penetrance, specificity and safety of viral tools in each system. In this regard, although we observed minimal inappropriate expression with our constructs, AAVs can form end-to-end concatemers with payload deletion and rearrangement 35 , a process that may induce expression in isolation 36 and could contribute (along with low TH expression) to the small population of TH − cells in projection-targeting experiments (Fig. 6f,g ). Alternatively, read-through in HSV lox-STOP-lox cassettes is possible, separate from INTRSECT constructs 7, 10 , and may be improved by alternative strategies (Supplementary Fig. 16a) . However, the absence of inappropriate expression in controls (Supplementary Fig. 14) suggests instead that targeting NAc-projecting cells may enrich for rare VTA TH − cells labeled by this transgenic line 8, 32 .
To create a single-AAV-based system capable of performing diverse Boolean logic on expression patterns, we built upon a substantial intron literature. Pioneering work adding heterologous introns to mammalian transgenes revealed that introns may function as independent units and that their addition to cDNAs can improve expression in vitro 20, 37 and in vivo 38 , which is consistent with our findings that introns inserted into ChR2-EYFP are spliced and enhance photocurrents. The use of intron-containing fluorophores may facilitate integrating introns into genetic tools for increased expression. We relied on splice-site descriptions 18, 19 in optimizing INTRSECT constructs and found that improved splicing correlated with increased photocurrents, emphasizing potential benefits of heterologous introns. For future work requiring additional introns, many options exist, although it may be sufficient to duplicate the two used here 39 .
The targetability of these cells will now allow for experiments characterizing their role in behavior, and together with C on /F off and C off /F on , these reagents may be of immediate utility in studies of interneuron modulation of hippocampal function 27 . For future work, validation of targeting in each system with multiple approaches is indicated. Here we used immunohistochemistry and morphologic analysis of targeted hippocampal cells; electrophysiological and other properties may also be employed. Differences observed in targeted cell types between similar transgenic mouse lines underscore the importance of considering recombinase expression pattern in transgenic animals, including bicistronic knock-ins. Production of additional transgenic animals expressing Flp will augment options for targeting refined cell populations.
Individual components of the INTRSECT system, including viral, recombinase and intron tools, may be separated or combined, as we have shown in targeting the NAc-projecting DA cells of the VTA. Beyond this example, cells in an 'upstream' brain region that project to two different downstream regions could be targeted to either include or exclude neurons according to projection pattern and may be combined with transgenic recombinase mouse lines for additional specificity ( Supplementary  Fig. 16 ). And although we have used ChR2-EYFP as a single targeted gene here, these tools also enable independent targeting and manipulation of multiple separately defined cell types within a single animal (Supplementary Fig. 16d) . INTRSECT tools have a modular design, may be integrated with existing reagents and animals, and may enable diverse expression logic for genetically encoded tools based on multiple genetic and/or connectivity factors. methods Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
online methods Statistical analysis. All statistical tests were chosen on the basis of normality of data and appropriateness of comparison to be analyzed by a particular approach. Data that were not normally distributed were either transformed to achieve normality or analyzed with a test that does not assume normal distribution. Estimation of variance was performed by Bartlett's test for equal variance (for ANOVAs) or by an F-test to compare variance (for unpaired t-tests). Variances were equal except when explicitly noted below. All error bars are reported as s.e.m. Figure 2e . n = 19 for ChR2-EYFP group, n = 12 for intron 1 group, n = 5 for intron 1 + lox group, n = 12 for intron 2 group, n = 5 for intron 2 + lox group, n = 5 for intron 1 + 2 group. Oneway type I ANOVA detected significant difference between the means: F 5,52 = 2.856, P = 0.0237. ChR2 and intron 2 + lox showed significant differences: P < 0.01, Dunnett's multiple comparison test. Results were pooled from data acquired across multiple transfections after ensuring that there were no significant withinconstruct differences across those transfections. Figure 2g . n = 8 for fSyn-ChR2-EYFP group, n = 5 for intron 1 + lox group, n = 6 for iC4A group ("intron 1 + lox optimized"). fSyn-ChR2-EYFP and iC4A showed significant differences: P < 0.05, Dunnett's multiple comparison test. Figure 3h . n = 6 for ChR2 group, n = 7 for C on /F on group. Unpaired two-sided t-test showed no significant difference: P = 0.0625. Figure 5h . n = 7 for fSyn-ChR2-EYFP group, n = 7 for C on /F on group, n = 7 for C on /F off group, n = 6 for F on /C off group. One-way type I ANOVA detected significant difference between the means: F 3,23 = 3.553, P = 0.0301. No significant differences were detected by Dunnett's multiple comparison tests.
Molecular cloning.
All single recombinase-dependent plasmids were constructed in an AAV-Ef1α backbone using the doublefloxed inverted open-reading-frame (DIO) strategy described previously 7, 8 . For construction of Flp-dependent recombinant AAV vectors, a DNA cassette carrying two pairs of incompatible FRT sites (FRT and F5 (ref. 17) ) was synthesized, and the ChR2-EYFP transgene was inserted between the two sites in the reverse orientation. The resulting cassette was cloned into a modified version of the pAAV2-MCS vector carrying the Ef1α promoter and the woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) to enhance expression. A similar strategy was used to construct the Dre-dependent plasmids, except because there was only one known rox site 16 , a novel rox site (rox2) was designed (5′-aactttaaataatgtcgattatttaaagtta-3′).
Three constructs were used to deliver cre into cells either in vivo or in vitro: AAV-Ef1α-Cre, AAV-Ef1α-Cre-p2A, AAV-EF1α-mCherry-IRES-Cre. The p2A peptide sequence was added where indicated as an immunostaining antigen. Similar constructs were used for Flp, Dre, VCre and SCre. Dre, VCre and SCre were human codon optimized and synthesized (DNA2.0). All AAV vectors were tested for in vitro expression before viral production. Updated maps are available at http://optogenetics.org/.
To create early multiple recombinase-dependent constructs, we used two separate approaches to modifying cDIO-hChR2(H134R)-EYFP. The first was by inverting the Ef1α promoter and flanking it with (5′ of the promoter) FRT and F5 in the forward direction and (3′ of the promoter) F5 and FRT in the reverse direction.
This construct effectively has two tandem DIO cassettes: one that encompasses the promoter and one that encompasses the ORF; thus, it was named 'double-inverted promoter/double-inverted ORF (DIP/DIO)' AAV-fDIP EF1a-cDIO hChR2 (H134R)-EYFP. Second, three other Cre-and Flp-dependent variants were created by leaving the promoter in the forward direction but nesting Flp recognition sites such that the 5′ forward direction sites were within one of the extracellular loops of ChR2 and the 3′ reverse direction sites were situated beyond the STOP codon. The portion of the ChR2 reading frame within the Flp recognition sites is initially in the forward direction, and the portion of the reading frame under control of only Cre is initially in the reverse direction. This second strategy retains an F5 site within the coding frame of ChR2 in the active conformation that occurs after the recombination catalyzed by Cre and Flp.
Short Target sites for insertion were determined using two criteria: first, that the two bases 5′ and the two bases 3′ of the insertion site match the exonic 5′ and 3′ consensus splice-site sequences, respectively; and second, that it would be unlikely that either fragment upstream or downstream of the reading frame translated in isolation would encode a functional protein. Splicing was tested in silico using NetGene2 (ref. 40 ; http://www.cbs.dtu.dk/services/ NetGene2/). To test intron function, these modified ChR2-EYFP fusion genes were inserted into a lentiviral backbone driven by the human synapsin (hSyn) promoter between BamHI and EcoRI, scaled up and purified using endotoxin-free (Qiagen endotoxinfree MaxiPrep) or low endotoxin (Invitrogen MaxiCard) plasmid preparation kits for small-batch lentiviral production.
To introduce recombinase recognition sites and enable directional control of individual exons, we first constructed a standard AAV backbone with a multiple cloning site downstream of either the hSyn or chimeric EF1α/HTLV promoter consisting (from 5′ to 3′) of BamHI, AscI, SalI, SpeI, KpnI, NheI, XbaI and EcoRI through oligo ligation. We next identified likely donor, branch-point and acceptor regions in the intron by comparison to consensus sequences 18, 19 . Proper exon-exon joining was ensured by directly joining the donor and acceptor sequences for each intron to their exonic partners, using overlapping PCR, without intervening restriction sites. To incorporate Flp control of all three exons, we separated incompatible sites 17 F3 and F5 by a short spacer sequence 8 and placed them between BamHI and AscI in the sense direction and between XbaI and EcoRI in the antisense direction. To incorporate Cre control of the second exon, we separated incompatible sites 22 lox2722 and loxN by the same spacer sequence and fused them in the sense direction to the CMV (intron 1) bp and intronic sequence and in the antisense direction to the IgE (intron 2) bp and intronic sequence and placed them between the SalI and SpeI and KpnI and NheI sites, respectively. F3 and loxN were chosen over FRT and loxP to decrease the possibility of chromosomal translocation 23 in transgenic animals that harbor either of these sites in their genome as legacy sequence from antibiotic resistance cassettes used during animal production. With this standard acceptor vector, exon direction for each Boolean value was determined, correct npg restriction sites were placed on exons via PCR addition and exons were ligated into the AAV acceptor vector. DNA was amplified as above for production of AAV. All constructs are freely available (http://www.optogenetics.org/).
Construct variants for control experiments were built as follows: truncated ChR2 for exon function experiments were created by (i) fusing the 3′ end of the exon 1 in-frame to EYFP, adding bases as necessary and (ii) fusing the 3′ end of the ChR2 portion of exon 2 to EYFP, adding an ATG start codon to the 5′ end and bases as necessary to the 3′ end to create a functional reading frame. Constitutive blue fluorescent protein (BFP) was added to constructs for cell health experiments by creating a BFP expression cassette consisting (5′ to 3′) of the hSyn promoter, BFP and poly(A) tail. This was then cloned into a unique MluI site 5′ of the hSyn promoter driving expression of cDIO-ChR2-EYFP, fDIO-ChR2-EYFP or C on /F on -ChR2-EYFP such that it was independently expressed from the recombinase-dependent expression cassette.
Flow cytometry. HEK293FT cells (Invitrogen) were grown in 24-well tissue culture plates to 90% confluence and transfected in duplicate with 800 ng total DNA with Lipofectamine 2000 (Invitrogen) following the manufacturer protocol. HEK cells were not routinely screened for Mycoplasma. Five days post transfection, cells were removed by enzymatic dissociation (TrypLE, Gibco), resuspended in PBS, pelleted at 200g for 5 min and resuspended in 500 µL PBS supplemented with 1 µg/mL propidium iodide (PI; Sigma), and then placed on ice under aluminum foil until analysis. Flow cytometry was completed on a Scanford analyzer at the Stanford Shared FACS Facility using settings optimized for side scatter (SS), forward scatter (FS), PI and EYFP acquisition using positive (ChR2-EYFP), negative (empty transfection) and dead (heat-killed; 95 °C for 3 min) conditions as controls. Live-cell populations used in comparisons were isolated from debris and dead cells in post hoc analysis by (i) negatively gating for PI + cells and (ii) positively gating for the high-density population in plotting FS vs. SS.
To unambiguously assess the expression of ChR2-EYFP in our samples, we subsampled each 30,000-point data set into 100 independent data sets. The log fluorescence (EYFP intensity) of each of these 100 subsets was then independently fit to a multicomponent Gaussian mixture model that chose whether the data set was best fit by one or by more than one curve, using the Bayesian information criterion to generate an accurate statistical estimate of the distinct subpopulations best accounting for each set of observations. Animals. Adult wild-type male and female transgenic parvalbumin-IRES-Cre 30 (Jax 008069), parvalbumin-2a-Cre 29 (Jax 012358), tyrosine hydroxylase-Cre (EMMA 00254) and somatostatin-Flp C57/BL6 mice were group housed up to four to a cage and kept on a reverse 12-h light/dark cycle with ad libitum food and water. Experimental protocols were approved by Stanford University IACUC and meet guidelines of the US National Institutes of Health guide for the Care and Use of Laboratory Animals. See the Supplementary Note for additional experimental animal information. mRNA isolation and cDNA synthesis. HEK293FT cells at 90% confluence were transfected with endotoxin-free DNA using Lipofectamine 2000 (Invitrogen) following the manufacturer protocol. Five days post transfection, RNA extraction was performed using reagents from the RNeasy Mini Kit (Qiagen). Cells were disrupted with lysis buffer and homogenized using QiaShredder homogenizer columns. Combined first-strand cDNA/PCR using the SuperScript III One-Step RT-PCR System (Invitrogen) was performed with the following reaction conditions: 45 °C × 30 min, 94 °C × 2 min, 40 cycles of 94 °C × 15 s, 45 °C × 30 s, 68 °C × 1 min, ending with 68 °C × 5 min using various combinations of primers (F, forward; R, reverse) as follows. Exon/strand/sequence (5′-3′): 1/F/agtggctgctcacttgtcct; 2/R/gcacaatccaagacaaaagaag; 2/F/agctggacggcgacgtaaac; 3/R/aagtcgtgctgcttcatgtg. The PCR product was gel purified and sequenced to determine splice junctions.
Mutagenesis. Intron mutations were introduced using QuikChange Lightning II Mutagenesis Kit (Agilent) with the following primers. F (5′-3′) and R (5′-3′): ChR2 C417A, ctgagcaacctcacaggtacgtgtcgggg and ccccgacacgtacctgtgaggttgctcag; intron 1 C4A, caacctcaccggtaagtgtcggggttgc and gcaaccccgacacttaccggtgaggttg; intron 1 polypyrimidine tract, gtgcttatgactctatttctcttctctttaggcctgagcaacgacta and tagtcgttgctcaggcctaaagagaagagaaatagagtcataagcac.
obtained on a Leica confocal microscope using 5×, 40×, and 63× objectives. All secondary antibodies (Jackson ImmunoResearch) were used at 1:500. Primary antibodies were 2a (Millipore ABS31, rabbit, 1:500 dilution), parvalbumin (Sigma P3088, mouse, 1:500), somatostatin (Santa Cruz Sc-7819, goat, 1:500), tyrosine hydroxylase (Aves TYH, chicken, 1:500), streptavidin-350 (Invitrogen S-11249, 1:500).
In vivo optrode recordings. In vivo recordings of recombinaseinduced ChR2 expression in hippocampus were performed as described previously 44 . Clampex software was used for both recording signals and controlling the 473-nm (CrystaLaser) 100-mW solid-state laser diode source coupled to the optrode. Slice electrophysiology. Coronal slices (300 µm) from mice previously injected with virus were prepared after intracardial perfusion with ice-cold, sucrose-containing artificial cerebrospinal fluid (ACSF; in mM): 85 NaCl, 75 sucrose, 2.5 KCl, 25 glucose, 1.25 NaH 2 PO 4 , 4 MgCl 2 , 0.5 CaCl 2 and 24 NaHCO 3 . Slices were incubated for 1 h at 32-34 °C and then transferred to an oxygenated standard ACSF solution at room temperature (in mM): 123 NaCl, 3 KCl, 26 NaHCO 3 , 2 CaCl 2 , 1 MgCl 2 , 1.25 NaH 2 PO 4 and 11 glucose, with synaptic transmission blockers d-2-amino-5-phosphonovaleric acid (APV; 25 µM), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f ]quinoxaline-2,3-dione (NBQX; 10 µM) and gabazine (10 µM). Electrophysiological recordings were performed at 32-34 °C. Slices were visualized with an upright microscope (BX61WI, Olympus) equipped with a 40× water-immersion objective and infrared differential interference contrast (IR-DIC) optics. Individual neuron recordings were obtained after identifying fluorescent protein expression without interruption of ACSF perfusion. Filtered light from a Spectra X Light engine (Lumencor) was coupled to the fluorescence port of the microscope and used to both view fluorescence and deliver light pulses for opsin activation. Power density of the blue light (475/28 nm) was 5 mW/mm 2 , measured with a power meter (Thorlabs). Whole-cell recordings were obtained with patch pipettes pulled from borosilicate glass capillaries (Sutter Instruments) with a horizontal puller (P-2000, Sutter Instruments) and contained the following internal solution (in mM): 125 K-gluconate, 10 KCl, 10 HEPES, 4 Mg 3 -ATP, 0.3 Na-GTP, 10 phosphocreatine, 1 EGTA, 8 biocytin. 1 µM tetrodotoxin was added to the external recording solution when necessary to eliminate escape spikes for peak photocurrent measurements. Recordings were made using a MultiClamp700B amplifier (Molecular Devices). Signals were filtered at 4 kHz and digitized at 10 kHz with a Digidata 1440A analog-digital interface (Molecular Devices). pClamp10.3 software (Molecular Devices) was used to record and analyze data. Peak and steady-state photocurrents were measured from a 1-s light pulse in voltage-clamp mode. Series resistances were carefully monitored, and recordings were not used if the series resistance changed by a large magnitude (by >20%) or reached 25 MΩ. Input resistance and capacitance were both calculated from the response to 10-mV voltage steps in voltage clamp, using steadystate current amplitude and recovery from the capacitive transient, respectively.
Slice histology. 300-µm acute slices used in electrophysiology recordings with biocytin-filled recording pipettes were prepared in a two-step process. Slices were first processed for immunohistochemistry by postfixing in 4% PFA with 0.2% picric acid in 0.1 M phosphate buffer (in mM: 80 Na 2 HPO 4 , 20 NaH 2 PO 4 ) for at least 1 d following recording, washed in 0.1 M phosphate buffer (PB) and incubated overnight at 4 °C with primary antibodies diluted in 0.05 M TBS (in mM: 42 Trizma HCl, 8 Trizma base, 154 NaCl) with 0.5% Triton X-100. The next day, slices were washed in 0.1 M TBS, incubated in secondary at room temperature for 3 h, washed in 0.1 M PB and mounted using Vectashield (Vector Laboratories). After imaging, slices were processed for bright-field morphological analysis.
For morphological analysis of axonal and dendritic arbors, slices were unmounted; washed in 0.1 M PB; treated with 1% H 2 O 2 to extinguish endogenous peroxidases; washed again; treated with 50%, 70%, and 50% EtOH steps; washed; and processed to form avidin-DH/biotin complexes (Vectastain ABC kit, Vector Laboratories) in 0.05 M TBS with 0.5% Triton X-100 overnight at 4 °C. The next day, after washing in 0.1 M PB, slices were reacted with 3,3′-diaminobenzidine tetrahydrochloride (0.015%, DAB substrate kit for peroxidase, Vector Laboratories), washed, dehydrated, cleared with Citrisolv (Fisherbrand) and mounted (DPX, Electron Microscopy Sciences). Morphology was resolved by examining shape and location of cell body, dendrites and axon; reconstructions were rendered with StereoInvestigator (MBF) and Photoshop (Adobe).
